Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Novartis
McKinsey
Chinese Patent Office
Express Scripts
Mallinckrodt
Covington
Citi
Chubb
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,693,115

« Back to Dashboard

Summary for Patent: 6,693,115
Title: Acid addition salts of hydropyridine derivatives
Abstract:Acid addition salts of 2-acetoxy-5-(.alpha.-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahyd rothieno[3,2-c]-pyridine. The acid addition salts of tetrahydrothienopyridine derivatives of the present invention exhibit excellent oral absorption, metabolization into the active compound, and platelet aggregation-inhibiting effects, low toxicity, and excellent storage and handling stabilities, and are useful as medicaments, preferably preventive or therapeutic agents (particularly therapeutic agents) for diseases caused by a thrombus or an embolus, still more preferably preventive or therapeutic agents (particularly therapeutic agents) for thrombosis or embolism.
Inventor(s): Asai; Fumitoshi (Tanashi, JP), Ogawa; Taketoshi (Tokyo, JP), Naganuma; Hideo (Tokyo, JP), Yamamura; Naotoshi (Nishitokyo, JP), Inoue; Teruhiko (Ube, JP), Nakamura; Kazuyoshi (Onoda, JP)
Assignee: Sankyo Company, Limited (Tokyo, JP) Ube Industries Ltd. (Ube, JP)
Application Number:10/329,629
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 6,693,115

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,693,115

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-205396Jul 06, 2000
Japan2000-266780Sep 04, 2000

International Patents Family Members for US Patent 6,693,115

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand 523416 ➤ Subscribe
Norway 328651 ➤ Subscribe
Norway 20030022 ➤ Subscribe
Mexico PA03000031 ➤ Subscribe
South Korea 20130118395 ➤ Subscribe
South Korea 20120062906 ➤ Subscribe
South Korea 20100105763 ➤ Subscribe
South Korea 20090033917 ➤ Subscribe
South Korea 20080021152 ➤ Subscribe
South Korea 20030014294 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Accenture
Mallinckrodt
Citi
AstraZeneca
Chinese Patent Office
Daiichi Sankyo
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot